Mental Health

The Effects of an Acute Dose of Cannabidiol on Health and Two-Mile Time Trial Performance-A Pilot Study.

TL;DR

An acute dose of CBD (300 mg) taken 2 h before a 2-mile run may potentially benefit runners in shorter distance competitions by increasing calm and relaxed feelings and reducing perceived effort at the halfway point without impairing performance or increasing gastrointestinal upset.

Key Findings

CBD treatment increased self-reported feelings of calm compared to placebo.

  • Participants reported a 21% increase in feelings of calm in the CBD treatment condition compared to placebo (p = 0.04)
  • Feelings were assessed using the State Trait Anxiety Inventory (STAI) completed after a 2-hour quiet sitting period following capsule consumption
  • Sample size was N = 12 (4 males, 8 females), mean age 25.5 ± 3.34 years
  • The dose administered was 300 mg of CBD in capsule form

CBD treatment increased self-reported feelings of relaxation compared to placebo.

  • Participants reported a 22% increase in feelings of relaxation in the CBD treatment condition compared to placebo (p = 0.02)
  • Feelings were measured after a 2-hour rest period following ingestion of 300 mg CBD or placebo capsules
  • The study used a randomized, cross-over design with two separate visits

CBD treatment reduced rating of perceived exertion (RPE) at the halfway point of the 2-mile run.

  • The CBD treatment group experienced an 8% reduction in average RPE at mile 1 of the run compared to placebo (p = 0.05)
  • RPE was measured during the run as a standard measure of perceived effort
  • No significant difference in RPE was reported at other measured time points based on the abstract

CBD treatment did not significantly affect 2-mile time trial run performance compared to placebo.

  • There was no significant difference in run performance time between CBD and placebo treatments
  • Participants completed a 2-mile treadmill run as fast as possible approximately 2 hours after capsule consumption
  • Heart rate and blood lactate were also measured during and after the run

CBD treatment did not significantly affect gastrointestinal symptoms, blood pressure, or heart rate variability compared to placebo.

  • There were no differences in the severity of gastrointestinal (GI) symptoms between CBD and placebo treatments
  • No significant differences were found in systolic blood pressure (SBP) or diastolic blood pressure (DBP) between treatments
  • Heart rate variability (HRV) did not differ significantly between CBD and placebo treatments
  • GI symptoms were assessed via questionnaire immediately after the 2-mile time trial
  • Resting SBP, DBP, and HRV were measured after the 2-hour quiet sitting period

The study used a randomized, cross-over design administering 300 mg CBD or placebo capsules 2 hours before testing.

  • Participants (N = 12; 4 males, 8 females) averaged 25.5 ± 3.34 years of age
  • Each participant completed two visits, receiving either CBD or placebo on each occasion in randomized order
  • After capsule consumption, subjects sat quietly for 2 hours before completing assessments and the time trial
  • Measures included STAI, resting SBP, DBP, HR, blood lactate, HRV, RPE during run, and post-run GI symptoms
  • The authors described this as a pilot study

What This Means

This research suggests that taking a 300 mg dose of cannabidiol (CBD) about two hours before a 2-mile run may make runners feel calmer and more relaxed, and may reduce how hard the run feels at the halfway point, without slowing them down or causing stomach problems. The study involved 12 recreational runners who completed the same test twice — once with CBD capsules and once with a placebo — allowing researchers to compare the effects directly within the same individuals. Participants reported feeling about 21% calmer and 22% more relaxed after taking CBD compared to placebo, and they rated their perceived effort about 8% lower at the one-mile mark during the CBD trial. Importantly, this research suggests that CBD did not hurt running performance, as finishing times were similar between the CBD and placebo conditions. It also did not cause significant changes in blood pressure, heart rate variability, or gastrointestinal discomfort — a common concern for runners. These findings are relevant given that CBD use among athletes is growing, particularly since it was removed from the World Anti-Doping Agency's prohibited list. However, this was a small pilot study with only 12 participants, so the results should be interpreted cautiously. The authors themselves describe it as exploratory, and larger, more rigorous studies would be needed to confirm these findings and better understand how CBD might affect athletes across different distances, intensities, and populations.

Have a question about this study?

Citation

Bell E, Elias B, Gutierrez S, Stewart L. (2026). The Effects of an Acute Dose of Cannabidiol on Health and Two-Mile Time Trial Performance-A Pilot Study.. Nutrients. https://doi.org/10.3390/nu18010029